Of diabetic patients, in DM+CAD+ group, 16% were insulin users, 64% were in treatment with antihyperglycemic agents, and 20% were not in treatment; in DM+CAD− group, the percentage of treatments were, respectively, 10% for insulin, 80% for antihyperglycemic drugs, and 10% were not treated. This evidence concerns the gene INS and diabetes mellitus.